🇺🇸 FDA
Patent

US 11447452

Agonists of peroxisome proliferator-activated receptor alpha and methods of use

granted A61PA61P27/02

Quick answer

US patent 11447452 (Agonists of peroxisome proliferator-activated receptor alpha and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P27/02